News

  • 6 November 2011

    FDA claims fastest drug approvals

    The US Food and Drug Administration (FDA) has claimed that it is approving drugs faster than its counterparts in other countries.

  • 6 November 2011

    FDA approves Bayer’s anti-clotting drug

    The US Food and Drug Administration (FDA) has approved Bayer Healthcare's anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of a stroke in people with an abnormal heart rhythm (non-valvular...

  • 4 November 2011

    Exelixis to commence prostate cancer drug trial

    Exelixis has announced that it will begin the pivotal Phase III '306 trial of cabozantinib in patients with metastatic castration-resistant prostate cancer by the end of 2011.

Close
Close
Close

Go Top